Growth Metrics

Lemaitre Vascular (LMAT) Raw Materials (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Raw Materials for 14 consecutive years, with $20.9 million as the latest value for Q4 2025.

  • Quarterly Raw Materials rose 9.33% to $20.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.9 million through Dec 2025, up 9.33% year-over-year, with the annual reading at $20.9 million for FY2025, 9.33% up from the prior year.
  • Raw Materials for Q4 2025 was $20.9 million at Lemaitre Vascular, roughly flat from $21.0 million in the prior quarter.
  • The five-year high for Raw Materials was $21.7 million in Q2 2025, with the low at $4.7 million in Q3 2021.
  • Average Raw Materials over 5 years is $15.6 million, with a median of $18.3 million recorded in 2023.
  • The sharpest move saw Raw Materials fell 7.92% in 2021, then soared 186.37% in 2022.
  • Over 5 years, Raw Materials stood at $5.9 million in 2021, then skyrocketed by 151.12% to $14.9 million in 2022, then rose by 22.8% to $18.3 million in 2023, then increased by 4.23% to $19.1 million in 2024, then increased by 9.33% to $20.9 million in 2025.
  • According to Business Quant data, Raw Materials over the past three periods came in at $20.9 million, $21.0 million, and $21.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.